| Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial U Chakravarthy, SP Harding, CA Rogers, SM Downes, AJ Lotery, ... Ophthalmology 119 (7), 1399-1411, 2012 | 973 | 2012 |
| Applied methods of cost-effectiveness analysis in healthcare AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth OUP Oxford, 2010 | 878 | 2010 |
| Liberal or restrictive transfusion after cardiac surgery GJ Murphy, K Pike, CA Rogers, S Wordsworth, EA Stokes, GD Angelini, ... New England Journal of Medicine 372 (11), 997-1008, 2015 | 838 | 2015 |
| Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature K Schwarze, J Buchanan, JC Taylor, S Wordsworth Genetics in Medicine 20 (10), 1122-1130, 2018 | 598 | 2018 |
| 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report 100,000 Genomes Project Pilot Investigators New England Journal of Medicine 385 (20), 1868-1880, 2021 | 484 | 2021 |
| The challenge of antimicrobial resistance: what economics can contribute LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ... Science 364 (6435), eaau4679, 2019 | 466 | 2019 |
| Effect of a strategy of a supraglottic airway device vs tracheal intubation during out-of-hospital cardiac arrest on functional outcome: the AIRWAYS-2 randomized clinical trial JR Benger, K Kirby, S Black, SJ Brett, M Clout, MJ Lazaroo, JP Nolan, ... Jama 320 (8), 779-791, 2018 | 460 | 2018 |
| Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study LJ Pankhurst, C del Ojo Elias, AA Votintseva, TM Walker, K Cole, J Davies, ... The Lancet Respiratory Medicine 4 (1), 49-58, 2016 | 378 | 2016 |
| The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom K Schwarze, J Buchanan, JM Fermont, H Dreau, MW Tilley, JM Taylor, ... Genetics in Medicine 22 (1), 85-94, 2020 | 257 | 2020 |
| Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial S Bhattacharya, K Harrild, J Mollison, S Wordsworth, C Tay, A Harrold, ... Bmj 337, 2008 | 253 | 2008 |
| DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model S Wordsworth, J Leal, E Blair, R Legood, K Thomson, A Seller, J Taylor, ... European heart journal 31 (8), 926-935, 2010 | 175 | 2010 |
| Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis SD Grosse, S Wordsworth, K Payne Genetics in Medicine 10 (9), 648-654, 2008 | 157 | 2008 |
| Collecting unit cost data in multicentre studies: creating comparable methods S Wordsworth, A Ludbrook, F Caskey, A Macleod The European Journal of Health Economics 6, 38-44, 2005 | 147 | 2005 |
| Early referral and planned initiation of dialysis: what impact on quality of life? FJ Caskey, S Wordsworth, T Ben, FT de Charro, C Delcroix, ... Nephrology Dialysis Transplantation 18 (7), 1330-1338, 2003 | 141 | 2003 |
| Sensitivity of willingness to pay estimates to the level of attributes in discrete choice experiments M Ryan, S Wordsworth Scottish Journal of Political Economy 47 (5), 504-524, 2000 | 138 | 2000 |
| Issues surrounding the health economic evaluation of genomic technologies J Buchanan, S Wordsworth, A Schuh Pharmacogenomics 14 (15), 1833-1847, 2013 | 127 | 2013 |
| Video-assisted thoracoscopic or open lobectomy in early-stage lung cancer E Lim, TJP Batchelor, J Dunning, M Shackcloth, V Anikin, B Naidu, ... NEJM evidence 1 (3), EVIDoa2100016, 2022 | 119 | 2022 |
| Cost‐minimisation analysis versus cost‐effectiveness analysis, revisited H Dakin, S Wordsworth Health economics 22 (1), 22-34, 2013 | 117 | 2013 |
| Why the NHS should do more bariatric surgery; how much should we do? R Welbourn, CW Le Roux, A Owen-Smith, S Wordsworth, JM Blazeby Bmj 353, 2016 | 102 | 2016 |
| Eliciting expert opinion for economic models: an applied example J Leal, S Wordsworth, R Legood, E Blair Value in Health 10 (3), 195-203, 2007 | 102 | 2007 |
James BuchananSenior Lecturer, Queen Mary University of LondonVerified email at qmul.ac.uk
